International Partner Search

Innovation & Technology Offer

Commercial partnership for Pharmaceutical companies involved in ophthalmology, glaucoma treatment and retinal diseases.

Country of Origin: Italy
Reference Number: TOIT20180711002
Publication Date: 20 September 2018

Summary

The company, an Italian company founded in 2009, proposes an Innovative Patent technology for the visual rehabilitation by means of  biofeedback. The company is searching for partners as pharmaceutical companies producing substances for glaucoma treatment and neuro-protection. The company objective is signing Commercial agreements with technical assistance, for testing and follow up of partners' treatment

Description

Company mission is to simplify the use of this important class of powerful diagnostic tools, often  restricted to  few specialists, and to make it smart and largely usable for the ophthalmologists and optometrists professionals.



The technology provides a test that is objective, non-invasive, fast, and easy to make and to understand by the patient and the user. The test is automatic, reliable, operator-independent, able to detect initial dysfunction of ganglion cells in Glaucoma patients before the occurrence of significant defects in the automated standard perimeter. The technology is adequate for monitoring of pharmacological treatment. This technology performs like an “electrocardiogram” of the eye that can detect bio-functional diseases of the cells much in advance than the anatomical changes occur.



The company is able to customize the system with different design and capabilities, based on a scientifically, widely recognized method.



The Company started with the commercialization of electrophysiology devices imported from one of the most important international brand in the field. Despite a recent brand, its R & D engineers come with a long experience inherited by, one of the company early providing vision electrophysiology devices in the world since 1977. 



In 2012, the company started developing his own line of a devices helping early glaucoma detection. Join with the device, the company has developed a software device that can run on the A10 hardware platform, intended for the visual rehabilitation by means of  biofeedback. Most recently it has been developed a multifocal ERG system, a sophisticated diagnostic tool able to maps the retinal photoreceptors functionality. 



The company are developing and improving a specific line of smart and easy devices for electrophysiology of vision, with other new features coming: with the aim to design and build complete workstations for visual electrophysiology .

Advantages and Innovations

The Technology is an Innovative technology: proprietary video pattern generation method implemented by software and hardware  for LCD, used in electrophysiology,  that positively impacts on performance, costs and sizes. Easy and smart to use software conception

The Technology represents a partnership challenge for pharmaceutical companies who produce substances for glaucoma treatment willing to support professionals with: (1) an early diagnostic tool, (2) a “tester” for the effectiveness of specific medicines or  supplements, and (3) a monitoring system the disease follow up.   We are able to customize instruments with different design and capabilities, based on a scientifically, widely recognized method.

Stage Of Development

Available for demonstration

Requested partner

Pharmaceutical companies who produce substances  for glaucoma treatment and  for other retinal diseases and who wish to aid field professionals customers with an early diagnostic tool that is a “tester” for the effectiveness of the the medicine or the supplements, and for monitoring the follow up of the disease.